Uger Robert

Chief Scientific Officer at Trillium Therapeutics Inc.

Sold, on record
$496k
Dollars the filings state
Form 4 sales
10
Latest Jul 7, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Trillium Therapeutics Inc.Unusual
    Jan 11, 2021 2021

    Sold 584 shares at $15.20 ($9k)

    Uger Robert, Chief Scientific Officer

    Sold 100% of holdings ($9k position)0 shares leftFiling

  2. 2 Form 4 sale Trillium Therapeutics Inc.Unusual
    Feb 9, 2021 +29 days

    Sold 7,147 shares at $12.77 ($91k)

    Uger Robert, Chief Scientific Officer

    Sold 100% of holdings ($91k position)0 shares left2x usual sizeFiling

  3. 3 Form 4 sale Trillium Therapeutics Inc.Unusual
    Mar 8, 2021 +27 days

    Sold 3,646 shares at $10.11 ($37k)

    Uger Robert, Chief Scientific Officer

    Sold 100% of holdings ($37k position)0 shares left0.7x usual sizeFiling

  4. 4 Form 4 sale Trillium Therapeutics Inc.Unusual
    Mar 12, 2021 +4 days

    Sold 2,917 shares at $11.97 ($35k)

    Uger Robert, Chief Scientific Officer

    Sold 100% of holdings ($35k position)0 shares left0.8x usual sizeFiling

  5. 5 Form 4 sale Trillium Therapeutics Inc.Unusual
    Apr 7, 2021 +26 days

    Sold 3,646 shares at $10.82 ($39k)

    Uger Robert, Chief Scientific Officer

    Sold 100% of holdings ($39k position)0 shares left1x usual sizeFiling

  6. 6 Form 4 sale Trillium Therapeutics Inc.Unusual
    May 7, 2021 +30 days

    Sold 3,646 shares at $9.30 ($34k)

    Uger Robert, Chief Scientific Officer

    Sold 100% of holdings ($34k position)0 shares left1x usual sizeFiling

  7. 7 Form 4 sale Trillium Therapeutics Inc.Unusual
    Jun 7, 2021 +31 days

    Sold 3,646 shares at $8.27 ($30k)

    Uger Robert, Chief Scientific Officer

    Sold 100% of holdings ($30k position)0 shares left1x usual sizeFiling

  8. 8 Form 4 sale Trillium Therapeutics Inc.Unusual
    Jul 7, 2021 +30 days

    Sold 3,646 shares at $9.00 ($33k)

    Uger Robert, Chief Scientific Officer

    Sold 100% of holdings ($33k position)0 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Uger Robert
Source
Jul 7, 2021Jul 9, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale3,646$33k100.0%UnusualSEC
Jun 7, 2021Jun 9, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale3,646$30k100.0%UnusualSEC
May 7, 2021May 11, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale3,646$34k100.0%UnusualSEC
Apr 7, 2021Apr 9, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale3,646$39k100.0%UnusualSEC
Mar 12, 2021Mar 15, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale2,917$35k100.0%UnusualSEC
Mar 8, 2021Mar 10, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale3,646$37k100.0%UnusualSEC
Feb 9, 2021Feb 10, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale7,147$91k100.0%UnusualSEC
Jan 11, 2021Jan 13, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale584$9k100.0%UnusualSEC
Jan 8, 2021Jan 12, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale8,517$134k100.0%UnusualSEC
Jan 7, 2021Jan 11, 2021Trillium Therapeutics Inc.Chief Scientific OfficerForm 4 sale3,646$54k100.0%UnusualSEC